Q: Why does the calculator now include eGFR and BMI, and what about the 30-year estimate?

PREVENT incorporates eGFR and BMI to reflect cardiovascular-kidney-metabolic (CKM) health, recognizing that kidney and metabolic status meaningfully affect cardiovascular risk. The 30-year estimate is most applicable to younger adults (roughly 30–59); for people over 59 a 30-year horizon is less reliable, so the 10-year estimate and shared decision-making should take precedence.

Q: Does PREVENT give a lower risk than the old equations, and what does that mean?

Generally, yes. The 2013 Pooled Cohort Equations are known to over-estimate risk in contemporary populations, and PREVENT — derived on a larger, more recent, more diverse cohort — typically returns lower 10-year estimates for the same patient. Clinically this can move some people below the thresholds that previously prompted preventive therapy, which is why decisions should rest on shared decision-making and risk-enhancing factors rather than a single number, and why the same equation should be used consistently when tracking a patient over time.

Q: Who is the PREVENT ASCVD model for, and who is it not for?

It is for primary prevention in adults aged 30–79 without established cardiovascular disease. It should not be used in patients with known ASCVD (secondary prevention), who already qualify for intensive risk reduction regardless of a calculated score, nor outside the validated age range. This calculator implements the base ASCVD outcome; the full PREVENT equations also estimate total cardiovascular disease (including heart failure), which is a broader endpoint than ASCVD alone.

Question 1

What is a good ASCVD score, and how is the 10-year ASCVD risk categorized?

Accepted Answer

Using the ACC/AHA 10-year strata, an ASCVD score below 5% is low risk, 5–7.4% is borderline, 7.5–19.9% is intermediate, and 20% or above is high risk. There is no single 'good' number — the categories are meant to frame a clinician–patient discussion about lifestyle and preventive therapy rather than to set a hard cut-off.

Question 2

Does this ASCVD calculator use the Pooled Cohort Equations?

Accepted Answer

No. It uses the 2023 AHA PREVENT equations, which are race-free and replaced the 2013 Pooled Cohort Equations. The older Pooled Cohort Equations required race as an input and tended to overestimate risk in contemporary populations, so PREVENT — derived on a larger, more recent, more diverse cohort — usually returns a lower 10-year ASCVD risk for the same patient.

Question 3

What is the ASCVD risk score and which equations does this calculator use?

Accepted Answer

The ASCVD risk score estimates a person's probability of a first atherosclerotic cardiovascular event (heart attack or stroke). This calculator uses the AHA PREVENT equations (base model), released by the American Heart Association in 2023 to replace the 2013 Pooled Cohort Equations. It returns both 10-year and 30-year risk and is intended for primary prevention in adults aged 30–79 without known cardiovascular disease.

Question 4

How does PREVENT differ from the older Pooled Cohort Equations?

Accepted Answer

PREVENT is race-free (the 2013 Pooled Cohort Equations required race, which is now recognized as a flawed model input), it adds two cardiovascular-kidney-metabolic measures—eGFR (kidney function) and BMI—and it provides both 10-year and 30-year risk. The Pooled Cohort Equations were known to overestimate risk in contemporary populations; PREVENT was developed on a larger, more recent and diverse cohort to address this.

Question 5

How should the risk categories guide management?

Accepted Answer

Using the ACC/AHA 10-year strata: <5% is low, 5–7.4% borderline, 7.5–19.9% intermediate, and ≥20% high. These categories are meant to support a clinician–patient discussion about lifestyle and, for higher-risk patients, guideline-recommended preventive therapy such as statins—they do not prescribe a specific drug or dose. Risk-enhancing factors (e.g., family history of premature ASCVD, chronic kidney disease, elevated Lp(a)) may shift management within these bands.

Question 6

Why does the calculator now include eGFR and BMI, and what about the 30-year estimate?

Accepted Answer

PREVENT incorporates eGFR and BMI to reflect cardiovascular-kidney-metabolic (CKM) health, recognizing that kidney and metabolic status meaningfully affect cardiovascular risk. The 30-year estimate is most applicable to younger adults (roughly 30–59); for people over 59 a 30-year horizon is less reliable, so the 10-year estimate and shared decision-making should take precedence.

Question 7

Does PREVENT give a lower risk than the old equations, and what does that mean?

Accepted Answer

Generally, yes. The 2013 Pooled Cohort Equations are known to over-estimate risk in contemporary populations, and PREVENT — derived on a larger, more recent, more diverse cohort — typically returns lower 10-year estimates for the same patient. Clinically this can move some people below the thresholds that previously prompted preventive therapy, which is why decisions should rest on shared decision-making and risk-enhancing factors rather than a single number, and why the same equation should be used consistently when tracking a patient over time.

Question 8

Who is the PREVENT ASCVD model for, and who is it not for?

Accepted Answer

It is for primary prevention in adults aged 30–79 without established cardiovascular disease. It should not be used in patients with known ASCVD (secondary prevention), who already qualify for intensive risk reduction regardless of a calculated score, nor outside the validated age range. This calculator implements the base ASCVD outcome; the full PREVENT equations also estimate total cardiovascular disease (including heart failure), which is a broader endpoint than ASCVD alone.

10-Year Risk	Category
< 5%	Low
5% – 7.4%	Borderline
7.5% – 19.9%	Intermediate
≥ 20%	High

ASCVD Risk Calculator

Input

About

Formula

Interpretation

References

FAQ

Related Calculators